{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:35:04Z","timestamp":1791048904394,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.tiv.2011.12.018","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T11:15:59Z","timestamp":1326194159000},"page":"396-405","source":"Crossref","is-referenced-by-count":69,"title":["Anti-leukemic effects of gallic acid on human leukemia K562 cells: Downregulation of COX-2, inhibition of BCR\/ABL kinase and NF-\u03baB inactivation"],"prefix":"10.1016","volume":"26","author":[{"given":"T.","family":"Chandramohan Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bharat Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aparna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle M.","family":"Arunasree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrani","family":"Achari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.V.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lakshmipathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Subramanyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Reddanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2011.12.018_b0005","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1158\/1535-7163.MCT-06-0483","article-title":"Gallic acid causes inactivating phosphorylation of cdc25A\/cdc25C-cdc2 via ATMChk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells","volume":"5","author":"Agarwal","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tiv.2011.12.018_b0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.leukres.2007.11.007","article-title":"Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1","volume":"32","author":"Arunasree","year":"2008","journal-title":"Leukemia Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0025","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jep.2009.05.022","article-title":"Chebulagic acid, a COX\u2013LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line","volume":"124","author":"Bharat Reddy","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tiv.2011.12.018_b0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"15","key":"10.1016\/j.tiv.2011.12.018_b0040","first-page":"6645","article-title":"Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits I-\u03baB\u03b1 kinase \u03b2. Mol","volume":"24","author":"C\u00e1rcamo","year":"2004","journal-title":"Cell Biol."},{"key":"10.1016\/j.tiv.2011.12.018_b0045","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood.V92.11.4220","article-title":"Proteasome inhibitors induce apoptosis in glucocorticoid resistant chronic lymphocytic leukemic lymphocytes","volume":"92","author":"Chandra","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tiv.2011.12.018_b0050","unstructured":"Chen, G., Wang, F., Trachootham, D., Huang, P., 2010. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion (doi:10.1016\/j.mito.2010.08.001)."},{"key":"10.1016\/j.tiv.2011.12.018_b0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tiv.2011.12.018_b0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00685668","article-title":"Quantification of the synergistic interaction of edatrexate and cisplatin in vitro","volume":"31","author":"Chou","year":"1993","journal-title":"Cancer Chemoth. Pharm."},{"key":"10.1016\/j.tiv.2011.12.018_b0075","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl-2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tiv.2011.12.018_b0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.critrevonc.2006.07.001","article-title":"Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic","volume":"61","author":"de Groot","year":"2007","journal-title":"Crit. Rev. Oncol. Hemat."},{"key":"10.1016\/j.tiv.2011.12.018_b0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/1381612043453126","article-title":"Cancer and cyclooxygenase-2 (COX-2) inhibition","volume":"10","author":"Evans","year":"2004","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.tiv.2011.12.018_b0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10637-009-9241-9","article-title":"Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1, 2-dimethyl hydrazine induced rat colon carcinogenesis","volume":"28","author":"Giftson","year":"2010","journal-title":"Invest. New Drug."},{"key":"10.1016\/j.tiv.2011.12.018_b0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2141.2002.03784.x","article-title":"Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukemia and are associated with reduced survival","volume":"119","author":"Giles","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tiv.2011.12.018_b0115","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2013advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.tiv.2011.12.018_b0120","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tiv.2011.12.018_b0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-2952(96)00181-5","article-title":"Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway","volume":"52","author":"Hanif","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.12.018_b0130","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1093\/nar\/22.24.5506","article-title":"A rapid and simple method for the isolation of apoptotic DNA fragments","volume":"22","author":"Hermann","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0135","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1182\/blood.V100.3.1068","article-title":"Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336","volume":"100","author":"Hoover","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.tiv.2011.12.018_b0140","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1055\/s-2000-8633","article-title":"Gallotannins and related polyphenols from Pistacia weinmannifolia","volume":"66","author":"Hou","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/j.tiv.2011.12.018_b0380","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1248\/bpb.18.1526","article-title":"Selective induction of cell death in cancer cells by gallic acid","volume":"18","author":"Inoue","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tiv.2011.12.018_b0150","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1096\/fj.02-0947fje","article-title":"Celecoxib activates a novel mitochondrial apoptosis signaling pathway","volume":"17","author":"Jendrossek","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.tiv.2011.12.018_b0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1142\/S0192415X98000373","article-title":"Mechanism of the protective effects of sumac gall extract and gallic acid on the progression of CCl4-induced acute liver injury in rats","volume":"26","author":"Kanai","year":"1998","journal-title":"Am. J. Chin. Med."},{"issue":"9","key":"10.1016\/j.tiv.2011.12.018_b0165","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s11095-009-9926-y","article-title":"Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice","volume":"26","author":"Kaur","year":"2009","journal-title":"Pharmaceut. Res."},{"issue":"7","key":"10.1016\/j.tiv.2011.12.018_b0175","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2174\/138945011795677764","article-title":"Biology of Cox-2: an application in cancer therapeutics","volume":"12","author":"Khan","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.tiv.2011.12.018_b0180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2003-04-1074","article-title":"In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib resistant Bcr-Abl positive cell lines","volume":"103","author":"La Rosee","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.tiv.2011.12.018_b0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/371346a0","article-title":"Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE","volume":"371","author":"Lazebnik","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.tiv.2011.12.018_b0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ijc.1322","article-title":"Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells","volume":"93","author":"Li","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tiv.2011.12.018_b0210","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0145-2126(97)00060-X","article-title":"Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine","volume":"21","author":"Liu","year":"1997","journal-title":"Leukemia Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2006.01.001","article-title":"Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells","volume":"245","author":"Madlener","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2011.12.018_b0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cncr.20338","article-title":"Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma","volume":"101","author":"Milella","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.tiv.2011.12.018_b0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tiv.2011.12.018_b0240","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.tiv.2011.03.023","article-title":"Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas\/FasL-mediated pathways","volume":"25","author":"Mou","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.tiv.2011.12.018_b0250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0968-0004(97)01085-2","article-title":"Caspases: killer proteases","volume":"22","author":"Nicholson","year":"1997","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tiv.2011.12.018_b0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tiv.2011.12.018_b0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2004.10.051","article-title":"Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells analysis of their possible relationship to changes in NF-\u043aB activation levels and in IAP gene expression","volume":"224","author":"Notarbartolo","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2011.12.018_b0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0022-1759(81)90039-9","article-title":"Criteria of cell killing in vitro","volume":"43","author":"Pullen","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tiv.2011.12.018_b0270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0006-291X(03)00586-2","article-title":"C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages","volume":"304","author":"Reddy","year":"2003","journal-title":"Biochem. Biophys. Res. Co."},{"issue":"10","key":"10.1016\/j.tiv.2011.12.018_b0275","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2174\/092986610792231537","article-title":"Kinetics and docking studies of a COX-2 inhibitor isolated from Terminalia bellerica fruits","volume":"17","author":"Reddy","year":"2010","journal-title":"Protein Peptide Lett."},{"issue":"9\u201310","key":"10.1016\/j.tiv.2011.12.018_b0280","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cca.2010.12.026","article-title":"Cyclooxygenase-2 in oncogenesis","volume":"412","author":"Rizzo","year":"2011","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.tiv.2011.12.018_b0285","first-page":"2441","article-title":"Changes in amino acid pool and utilization during apoptosis in HL-60 cells induced by epigallocatechin gallate or gallic acid","volume":"21","author":"Sakagami","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0290","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate-a new oral targeted therapy","volume":"346","author":"Savage","year":"2002","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.tiv.2011.12.018_b0305","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1158\/0008-5472.CAN-04-0206","volume":"64","author":"Shishodia","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0310","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-\u043aB is suppressed by curcumin (diferuloylmethane)","volume":"270","author":"Singh","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2011.12.018_b0320","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.phymed.2007.03.017","article-title":"Betanin a betacyanin pigment purified from fruits of Opuntia ficus-indica induces apoptosis in human chronic myeloid leukemia Cell line-K562","volume":"14","author":"Sreekanth","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tiv.2011.12.018_b0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bcp.2004.02.025","article-title":"Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line\u2013K 562","volume":"68","author":"Subhashini","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.12.018_b0330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2004.11.002","article-title":"Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro","volume":"224","author":"Subhashini","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2011.12.018_b0335","first-page":"4903","article-title":"Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells","volume":"62","author":"Tang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0345","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10555-007-9096-5","article-title":"Cyclooxygenases, prostanoids, and tumor progression","volume":"26","author":"Wang","year":"2007","journal-title":"Cancer Metast. Rev."},{"key":"10.1016\/j.tiv.2011.12.018_b0350","first-page":"2029","article-title":"Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines","volume":"62","author":"Waskewich","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"THE BCR-ABL sTORY: bench to bedside and back","volume":"22","author":"Wong","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.tiv.2011.12.018_b0370","first-page":"2821","article-title":"Gallic acid induces G0\/G1 phase arrest and apoptosis in human leukemia HL-60 cells through inhibiting Cyclin D and E, and activating mitochondria-dependent pathway","volume":"31","author":"Yeh","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tiv.2011.12.018_b0375","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajh.20542","article-title":"Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of COX-2 expression and are synergistic with hydroxyurea or imatinib","volume":"81","author":"Zhang","year":"2006","journal-title":"Am. J. Hematol."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233311003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233311003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T15:02:00Z","timestamp":1593529320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233311003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0887233311003444"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2011.12.018","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}